Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priyathama Vellanki

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Evidence-Based Medicine|February 5, 2016
Detemir is non-inferior to NPH insulin in women with pregestational type 2 diabetes and gestational diabetes mellitusPriyathama Vellanki, Guillermo Umpierrez
The Lancet. Diabetes & Endocrinology|September 5, 2021
Diabetic ketoacidosis risk during the COVID-19 pandemicPriyathama Vellanki, Guillermo E Umpierrez
Diabetes Care|July 25, 2024
Response to Comment on Kaminski et al. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care 2024;47:267-271Priyathama Vellanki, Guillermo E Umpierrez
Current Diabetes Reports|April 2, 2017
Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA)Ketan K Dhatariya, Priyathama Vellanki
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 24, 2017
DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRICAN AMERICANS WITH TYPE 2 DIABETESPriyathama Vellanki, Guillermo E Umpierrez
Diabetes Care|August 24, 2018
Increasing Hospitalizations for DKA: A Need for Prevention ProgramsPriyathama Vellanki, Guillermo E Umpierrez
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 19, 2026
Ketosis-Prone Type 2 Diabetes Mellitus: Three Decades of Clinical, Pathophysiologic, and Therapeutic InsightsGuillermo Umpierrez, Priyathama Vellanki, Omolade Oladejo
Diabetes Care|January 23, 2019
Comment on Desai et al. Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis. Diabetes Care 2018;41:1631-1638Rodolfo J Galindo, Cesar Zambrano, Priyathama Vellanki
AACE Clinical Case Reports|April 14, 2021
Clinical Case Report: Dissociation of Clinical Course of Coexisting Autoimmune Hepatitis and Graves DiseaseAesha M Patel, Camille Stanback, Priyathama Vellanki
Endocrinology and Metabolism Clinics of North America|February 8, 2023
Intervention with Therapeutic Agents, Understanding the Path to Remission to Type 2 Diabetes: Part 2Shuai Hao, Guillermo E Umpierrez, Priyathama Vellanki
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Evidence-Based Medicine|February 5, 2016
Detemir is non-inferior to NPH insulin in women with pregestational type 2 diabetes and gestational diabetes mellitusPriyathama Vellanki, Guillermo Umpierrez
The Lancet. Diabetes & Endocrinology|September 5, 2021
Diabetic ketoacidosis risk during the COVID-19 pandemicPriyathama Vellanki, Guillermo E Umpierrez
Diabetes Care|July 25, 2024
Response to Comment on Kaminski et al. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care 2024;47:267-271Priyathama Vellanki, Guillermo E Umpierrez
Current Diabetes Reports|April 2, 2017
Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA)Ketan K Dhatariya, Priyathama Vellanki
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 24, 2017
DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRICAN AMERICANS WITH TYPE 2 DIABETESPriyathama Vellanki, Guillermo E Umpierrez
Diabetes Care|August 24, 2018
Increasing Hospitalizations for DKA: A Need for Prevention ProgramsPriyathama Vellanki, Guillermo E Umpierrez
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 19, 2026
Ketosis-Prone Type 2 Diabetes Mellitus: Three Decades of Clinical, Pathophysiologic, and Therapeutic InsightsGuillermo Umpierrez, Priyathama Vellanki, Omolade Oladejo
Diabetes Care|January 23, 2019
Comment on Desai et al. Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis. Diabetes Care 2018;41:1631-1638Rodolfo J Galindo, Cesar Zambrano, Priyathama Vellanki
AACE Clinical Case Reports|April 14, 2021
Clinical Case Report: Dissociation of Clinical Course of Coexisting Autoimmune Hepatitis and Graves DiseaseAesha M Patel, Camille Stanback, Priyathama Vellanki
Endocrinology and Metabolism Clinics of North America|February 8, 2023
Intervention with Therapeutic Agents, Understanding the Path to Remission to Type 2 Diabetes: Part 2Shuai Hao, Guillermo E Umpierrez, Priyathama Vellanki
Pageof 8